News Releases
- Notice Regarding Discontinuation of Development of GYM329 (Emugrobart) in Spinal Muscular Atrophy (SMA) and Facioscapulohumeral Muscular Dystrophy (FSHD)
- Chugai Files for the Medical Device Component of the Port Delivery Platform with ranibizumab in Japan
- Chugai Selected as a “Nadeshiko Brand” for FY2025
Science and Technology
Science and Technology
Careers at Chugai
Careers at Chugai
Videos
CPR celebrates 10th Anniversary